D. Villeneuve

The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data.

S. Hembruff, A. Parissenti, D. Villeneuve, 2005, Analytical biochemistry.

Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure

Baoqing Guo, S. Hembruff, A. Parissenti, 2004, Breast Cancer Research and Treatment.

Potent Killing of Paclitaxel- and Doxorubicin-resistant Breast Cancer Cells by Calphostin C Accompanied by Cytoplasmic Vacuolization

Baoqing Guo, S. Hembruff, A. Parissenti, 2003, Breast Cancer Research and Treatment.

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells

A. Parissenti, A. Chadderton, D. Villeneuve, 2000, Breast Cancer Research and Treatment.

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

Baoqing Guo, S. Hembruff, A. Parissenti, 2008, BMC Cancer.

Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells

K. Reed, S. Hembruff, A. Parissenti, 2008, Epigenetics.